Methotrexate and folates in rheumatoid arthritis;Metotreksat og folater ved reumatoid artritt

Tidsskrift for den Norske Laegeforening

Volumn 119, Issue 4, 1999, Pages 534-537

  Endresen, Gerhard K M ^a   Husby, Gunnar ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; FOLINATE CALCIUM; FOLINIC ACID; FOLINSYRE; METHOTREXATE; UNCLASSIFIED DRUG;

DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG MIXTURE; FOLIC ACID DEFICIENCY; HUMAN; MAJOR CLINICAL STUDY; NUTRITIONAL STATUS; RHEUMATOID ARTHRITIS; SHORT SURVEY;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FOLIC ACID; FOLIC ACID DEFICIENCY; HUMANS; METHOTREXATE; RANDOMIZED CONTROLLED TRIALS;

EID: 0033540614     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (32)

1. Weinblatt ME, Maier AL. Longterm experience with low dose weekly methotrexate in rheumatoid arthritis. J Rheumatol 1990; 17 (suppl 22): 33-8.
2. Bannwarth B, Labat L, Monde Y, Schaeverbeke T. Methotrexate in rheumatoid arthritis: an update. Drugs 1994; 47: 25-50.
3. Kremer JM. Methotrexate update. Scand J Rheumatol 1996; 25: 341-4.
4. Alarcón GS, López-Méndez A, Walter J, Boerbooms AMT, Russell AS, Furst DE et al. Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysis. J Rheumatol 1992; 19: 868-73.
5. Furst DE, Koehnke R, Burmeister LF, Kohler J, Cargill I. Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis. J Rheumatol 1989; 16: 313-20.
6. Alarcón GS, Tracy IC, Blackburn WD. Methotrexate in rheumatoid arthritis: toxic effects as the major factor in limiting long-term treatment. Arthritis Rheum 1989; 32: 671-6.
7. Nygaard H. Pancytopeni ved lavdose metotrexatbehandling hos pasienter med reumatoid artritt. Tidsskr or Lægeforen 1993; 113: 2805-7.
8. Morgan SL, Baggott JE, Altz-Smith M. Folate status of rheumatoid arthritis patients receiving long-term, low-dose methotrexate therapy. Arthritis Rheum 1987; 30: 348-56.
9. Andersen LS, Hansen EL, Knudsen JB, Wester JU, Hansen GVO, Hansen TM. Prospectively measured red cell folate levels in methotrexate treated patients with rheumatoid arthritis: relation to withdrawal and side effects. J Rheumatol 1997; 24: 830-7.
10. Allen RH. Megaloblastic anemias. I: Bennett JC, Plum F, red. Cecil textbook of medicine. Philadelphia: Saunders, 1996: 843-51.
11. Fairbanks VF, Klee GG. Biochemical aspects of hematology. I: Tietz NW, red. Textbook of clinical chemistry. Philadelphia: Saunders, 1986: 1495-588.
12. Grosflam J, Weinblatt ME. Methotrexate: mechanism of action, pharmacokinetics, clinical indications, and toxicity. Curr Opin Rheumatol 1991; 3: 363-8.
13. Sinnett MJ, Groff GD, Raddatz DA, Franck WA, Bertino JS. Methotrexate pharmacokinetics in patients with rheumatoid arthritis. J Rheumatol 1989; 16: 745-8.
14. Sonneveld P, Schultz FW, Nooter K, Hählen K. Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in plasma and bone marrow of children receiving low-dose oral methotrexate. Cancer Chemother Pharmacol 1986; 18: 111-6.
15. Segal R, Yaron M, Tartakovsky B. Methotrexate: mechanism of action in rheumatoid arthritis. Semin Arthritis Rheum 1990; 20: 190-9.
16. Cronstein BN. Molecular therapeutics: methotrexate and its mechanism of action. Arthritis Rheum 1996; 39: 1951-60.
17. Mao Z, Pan J, Kalman TI. Design and synthesis of histidine analogues of folic acid and methotrexate as potential folylpolyglutamate synthetase inhibitors. J Med Chem 1996; 39: 4340-4.
18. Huennekens FM. In search of dihydrofolate reductase. Protein Science 1996; 5: 1201-8.
19. Hanrahan PS, Russell AS. Concurrent use of folinic acid and methotrexate in rheumatoid arthritis. J Rheumatol 1988; 15: 1078-80.
20. Tishler M, Caspi D, Fishel B, Yaron M. The effects of leucovorin (folinic acid) on methotrexate therapy in rheumaoid arthritis patients. Arthritis Rheum 1988; 31: 906-8.
21. Buckley LM, Vacek PM, Cooper SM. Adminstration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis. J Rheumatol 1990; 17: 1158-61.
22. Morgan SL, Baggott JE, Vaughn WH, Young PK, Austin JV, Krumdieck CL et al. The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 1990; 33: 9-18.
23. Joyce DA, Will RK, Hoffman DM, Laing B, Blackbourn SJ. Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid. Ann Rheum Dis 1991; 50: 913-4.
24. Stewart KA, Mackenzie AH, Clough JD, Wilke WS. Folate supplementation in methotrexate-treated rheumatoid arthritis patients. Semin Arthritis Rheum 1991; 20: 332-8.
25. Shiroky JB, Neville C, Esdaile JM, Choquette D, Zummer M, Hazeltine M et al. Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis: results of a multicenter randomized, double-blind, placebo-controlled trial. Arthritis Rheum 1993; 36: 795-803.
26. Weinblatt ME, Maier AL, Coblyn JS. Low dose leucovorin does not interfere with the efficacy of methotrexate in rheumatoid arthritis: an 8 week randomized placebo controlled trial. J Rheumatol 1993; 20: 950-2.
27. Morgan SL, Baggott JE, Vaughn WH, Austin JS, Veitch TA, Lee JY et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis: a double-blind, placebo-controlled trial. Ann Intern Med 1994; 121: 833-41.
28. Jobanputra P, Hunter M, Clark D, Lambert CM, Hurst NP. An audit of methotrexate and folic acid for rheumatoid arthritis: experience from a teaching centre. Br J Rheumatol 1995; 34: 971-5.
29. Ortiz Z, Shea B, Suarez-Almazor ME, Moher D, Wells GA, Tugwell P. The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis: a metaanalysis of randomized controlled trials. J Rheumatol 1998; 25: 36-43.
30. Leeb BF, Witzmann G, Ogris E, Studnicka-Benke A, Andel I, Schweitzer H et al. Folic acid and cyanocobalamin levels in serum and erythrocytes during low-dose methotrexate therapy of rheumatoid arthritis and psoriatic arthritis patients. Clin Exp Rheumatol 1995; 13: 459-63.
31. Shiroky JB. The use of folates concomitantly with low-dose pulse methotrexate. Rheum Dis Clin North Am 1997; 23: 969-80.
32. Felleskatalog over farmasoytiske spesialpreparater markedsført i Norge: 40. utgave mars 1998 med senere tillegg. Oslo: Felleskatalogen AS, 1998.